Another Sign of a Growing AI Mania
Artificial Intelligence (AI) is becoming impossible to ignore. And on Wednesday, we saw a clear example of that. Nvidia (NVDA), the uncontested AI market darling, announced a $50 million investment in Recursion Pharmaceuticals (RXRX) – a biotech company that uses AI to discover new drugs. And the market went wild. RXRX soared 100% at the open and closed with a stunning 78% gain. Which leads us to ask ourselves... Is this another sign of a growing AI mania, or is this the beginning of one of the most important technology stories of our time? After all, it isn't just tech stocks benefiting from a surging interest in AI anymore. Now, the biotech industry can be an AI investment. And you can be sure... stocks in more and more industries will soon associate themselves with AI, too. So, how do you separate the companies who are actually using AI to grow their business from the dozens of companies trying to take advantage of this trend? And furthermore, is this technology something Americans should even be investing in? That's what Marc Chaikin will talk about on the night of July 19 at 8 pm Eastern (click here to save your spot). He'll share exactly how this AI mania is taking shape... which AI stocks to avoid... and help you find the real opportunities to position yourself to grow your wealth thanks to this breakthrough innovation. I encourage you to tune in and reserve your spot. Whether you've been following the advancements in AI closely... or if you simply want to get up to speed on what's happening... I encourage you to RSVP right away. No matter what your interest level, we can promise you will walk away from Marc's discussion on July 19 understanding the potential of AI in a way you never have before. Click here for the full details and to RSVP (free). Regards, Marc Gerstein
Director of Research, Chaikin Analytics | 
Post a Comment
Post a Comment